PRIMPERAN

This brand name is authorized in Cyprus, Estonia, Finland, France, Hong Kong SAR China, Japan, Mexico, Netherlands, Spain, Tunisia, Turkey.

Active ingredients

The drug PRIMPERAN contains one active pharmaceutical ingredient (API):

1	Metoclopramide hydrochloride monohydrate UNII W1792A2RVD - METOCLOPRAMIDE HYDROCHLORIDE
	The action of metoclopramide is closely associated with parasympathetic nervous control of the upper gastro-intestinal tract where it has the effect of encouraging normal peristaltic action. This provides for a fundamental approach to the control of those conditions where disturbed gastrointestinal motility is a common underlying factor.
	Read more about Metoclopramide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A03FA01	Metoclopramide	A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03F Propulsives → A03FA Propulsives
Discover more medicines within A03FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1763984
ES	Centro de información online de medicamentos de la AEMPS	40256, 40257, 41446
FI	Lääkealan turvallisuus- ja kehittämiskeskus	028761, 388694, 388702
FR	Base de données publique des médicaments	61729093, 62684103, 65529325, 68968199
HK	Department of Health Drug Office	07173
JP	医薬品医療機器総合機構	2399004C1077, 2399004F1200, 2399004Q1090, 2399401A1083
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	62878
NL	Z-Index G-Standaard	13722190, 13722220
NL	Z-Index G-Standaard, PRK	108, 6912, 6920
TN	Direction de la Pharmacie et du Médicament	9000491H, 9000492, 9000492H, 9000494H, 9043911, 9043912
TR	İlaç ve Tıbbi Cihaz Kurumu	8699578753511, 8699578753528